Clinical Trials on Acute Respiratory Viral Infections in Russian Federation

Total 589 results

SPP Pharmaclon Ltd.

Completed

Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19

COVID-19 Respiratory Infection | Acute Respiratory Disease

Russian Federation
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Viral Respiratory Infection | Acute Viral Upper Respiratory Infections

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Active, not recruiting

Study of Safety and Efficacy of the Drug Cycloferone in Patients With Acute Respiratory Viral Infection

Acute Respiratory Viral Infection

Russian Federation
Nearmedic Plus LLC

Completed

Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

Influenza | Respiratory Viral Infection | Acute Upper Respiratory Tract Infection

Russian Federation
Nearmedic Plus LLC

Completed

Kagocel® for the Prevention of ARVI and Influenza in Young People

Influenza | Respiratory Viral Infection | Acute Upper Respiratory Tract Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Acute Respiratory Infection

Russian Federation
Moscow Department of Health
Moscow State University of Medicine and Dentistry; National Research Center... and other collaborators

Completed

The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents

Covid19 | Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection | Flu | Viral Infection

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

Influenza | Acute Respiratory Infection

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Covid19 | SARS-CoV Infection

Russian Federation
SPP Pharmaclon Ltd.

Completed

Study of the Use of the Drug Ingaron in Patients With COVID-19

COVID-19 Respiratory Infection | Viral Pneumonia

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

Influenza | Respiratory Viral Infection

Russian Federation
PHARMENTERPRISES LLC

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers

Influenza | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Burnasyan Federal Medical Biophysical Center

Completed

An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19

Pneumonia | Septic Shock | Hypoxemia | Acute Respiratory Insufficiency | Acute Respiratory Tract Infection

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Acute Respiratory Viral Infections

Russian Federation, Kazakhstan
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

Acute Respiratory Viral Infections

Russian Federation
SPP Pharmaclon Ltd.

Completed

Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19

COVID-19 Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure (COVID-VENT)

SARS Pneumonia

Russian Federation
Nearmedic Plus LLC

Completed

Treatment of Influenza and ARVI in Children by Kagocel ®

Influenza | Acute Upper Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
PHARMENTERPRISES LLC

Completed

Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections

Influenza | Acute Respiratory Viral Infections

Russian Federation
Concern GRANIT
Samara State Medical University

Completed

Clinical Trial of a Medical Device "Device for Non-invasive Electromagnetic Therapy "TOR" in the Treatment of COVID-19"

Coronavirus Infection COVID-19

Russian Federation
Materia Medica Holding

Completed

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Acute Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Not yet recruiting

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

Viral Infection COVID-19

Russian Federation
Northern State Medical University
Helse Nord

Terminated

Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (MB-NO)

Sepsis

Russian Federation
PHARMENTERPRISES LLC
RSV Therapeutics LLC

Completed

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

Influenza | Acute Respiratory Viral Infections

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Active, not recruiting

Severity of COVID-19 and Vitamin D Supplementation

COVID-19 Respiratory Infection

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Completed

COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation

COVID-19 Respiratory Infection

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Recruiting

Russian Cardiovascular Registry of COVID-19

Cardiovascular Diseases | Covid19 | Acute Cardiovascular Disease

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Chita State Regional Clinical Hospital Number 1

Recruiting

Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 (SPIDEX-II)

Coronavirus Infection | Pneumonia, Viral

Russian Federation
Federal Research Clinical Center of Federal Medical...

Completed

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19 (COVID-VIT)

SARS-CoV2 Infection

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome (COVID-NIV)

Covid19 | ARDS

Russian Federation
Gamaleya Research Institute of Epidemiology and...

Unknown

The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older

Coronavirus Infection

Russian Federation
Pirogov Russian National Research Medical University
Pfizer

Unknown

Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19 (OPTIMIST)

Covid19

Russian Federation
National Research Center for Preventive Medicine
National Medical and Surgical Center named after N.I. Pirogov of the Ministry...

Active, not recruiting

Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia (TARGET-VIP)

COVID 19

Russian Federation
Tomsk National Research Medical Center of the Russian...
Siberian State Medical University

Completed

Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement (NICOR)

Coronavirus Infection | Pneumonia, Viral | Hypoxemia

Russian Federation
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Respiratory Viral Infection

Russian Federation
Biosurf LLC.

Active, not recruiting

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

ARDS Due to COVID-19

Russian Federation
Valenta Pharm JSC
Atlant Clinical Ltd.

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
Biocad

Terminated

Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) (COVER)

COVID-19 | Coronavirus Infection

Russian Federation
Chumakov Federal Scientific Center for Research...

Completed

Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

Coronavirus Infections | Polio | Vaccine

Russian Federation
Federal State Budgetary Institution, Pulmonology...
Moscow State University of Medicine and Dentistry; Medsi Clinic #1, Moscow

Unknown

Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia (MICOV)

COVID-19 | Viral Pneumonia

Russian Federation
I.M. Sechenov First Moscow State Medical University

Unknown

Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases

Chronic Obstructive Pulmonary Disease | Bronchitis | Acute Respiratory Infection | Community-acquired Pneumonia

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Completed

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

Increased Risk of SARS-CoV-2 Infection

Russian Federation
St. Petersburg Research Institute of Vaccines and...

Completed

Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine

Vaccine Reaction | Influenza | Influenza, Human | Vaccination; Infection | Influenza Viral Infections

Russian Federation

Clinical Trials on Acute Respiratory Viral Infections in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations